1. Scrip
  2. >>R&D
  3. >>Clinical Trials

Oxford’s Sarah Gilbert Outlines Coronavirus Vaccine Plans

Hopes COVID-19 Jab And Manufacturing Capacity Ready By September

 
• By Sten Stovall

Oxford University vaccines expert Sarah Gilbert says the first UK vaccine candidate to prevent the SARS-CoV-2 coronavirus will begin clinical testing in healthy volunteers next week and that “prospects are very good” an effective COVID19 jab could be available by September.

Covid-19
“We need to make vaccine for the world.” - Sarah Gilbert • Source: Shutterstock

Sarah Gilbert, who is a professor of vaccinology at the University of Oxford in the UK and a leading scientist at the university’s Jenner Institute, has outlined to the media her team’s plans to advance a vaccine using recombinant DNA techniques to create a SARS-CoV-2 antigen and embedding it within a primate adenovirus vector. She expressed the hope and aim of having a viable anti-COVID-19 product “available for global use” by September.

Gilbert’s team of experts was awarded a £2

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Clinical Trials

More from R&D